Screener
Generate Biomedicines, Inc. GENB Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q2 '25 | ||
|---|---|---|---|---|---|
| Liquidity | |||||
| Current ratio | 8.3×— | 9.2×— | 2.9×— | —— | |
| Leverage | |||||
| Debt-to-equity | 0.1×— | 0.1×— | —— | —— | |
| Per Share | |||||
| Book value per share | $3.56+123% | $7.94+155% | —— | -$15.69— | |
| Valuation | |||||
| Market capitalization | $1.86B+19.8% | $1.59B— | —— | —— | |
| Price / book | 4.1×— | 3.1×— | —— | —— |
FAQ
- Where do Generate Biomedicines, Inc.'s ratios come from?
- Every ratio is computed from Generate Biomedicines, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
